ALPHA PRO TECH LTD APT
NYSE American · XASE · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 1993-10-28
ALPHA PRO TECH LTD financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59.1M | $57.8M | $61.2M | $62.0M | $68.6M | $102.7M | $46.7M | $46.6M | $44.0M | — |
| Gross profit | $22.5M | $22.9M | $22.8M | $21.7M | $25.3M | $50.5M | $17.0M | $17.7M | $17.5M | $17.0M |
| R&D expense | — | — | — | — | — | — | — | — | $0 | $0 |
| SG&A expense | $17.8M | $18.6M | $17.8M | $16.2M | $16.6M | $18.2M | $13.3M | $13.3M | $14.0M | $12.8M |
| Operating income | $3.8M | $3.4M | $4.1M | $4.7M | $7.9M | $31.6M | $3.0M | $3.9M | $2.9M | $3.7M |
| Income tax | $1.1M | $1.1M | $1.2M | $1.1M | $1.7M | $5.4M | $680,000 | $789,000 | $1.0M | $1.0M |
| Net income | $3.5M | $3.9M | $4.2M | $3.3M | $6.8M | $26.9M | $3.0M | $3.6M | $2.6M | $3.2M |
| EPS (diluted) | $0.33 | $0.35 | $0.35 | $0.26 | $0.50 | $1.92 | $0.23 | $0.26 | $0.18 | $0.19 |
| Operating cash flow | $2.4M | $5.7M | $8.5M | $4.3M | -$480,000 | $18.3M | $3.1M | $2.0M | $4.0M | $6.8M |
| Free cash flow | $1.7M | $1.9M | $7.7M | $3.8M | -$3.0M | $17.1M | $1.8M | $1.4M | $2.8M | $6.6M |
| Cash & equivalents | $17.0M | $18.6M | $20.4M | $16.3M | $16.3M | $23.3M | $6.5M | $7.0M | $8.8M | $9.5M |
| Inventory | $23.6M | $22.7M | $20.1M | $24.4M | $25.0M | $16.7M | $11.3M | $9.9M | $10.2M | $11.0M |
| Total assets | $74.1M | $73.7M | $68.8M | $64.8M | $67.0M | $68.7M | $38.1M | $34.3M | $34.1M | $35.9M |
| Total liabilities | $11.7M | $11.5M | $7.2M | $4.0M | $5.3M | $9.1M | $4.9M | $2.1M | $2.8M | $3.3M |
| Shareholders' equity | $62.5M | $62.2M | $61.6M | $60.8M | $61.8M | $58.8M | $32.9M | $32.2M | $31.3M | $32.7M |
Growth · year-over-year · Revenue CAGR 3.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +2.3% | -5.5% | -1.2% | -9.7% | -33.2% | +120.1% | +0.1% | +5.9% | — | — |
| Net income growth | -10.1% | -6.2% | +27.6% | -51.4% | -74.9% | +796.3% | -17.2% | +37.7% | -16.9% | +204.3% |
| EPS growth | -5.7% | +0.0% | +34.6% | -48.0% | -74.0% | +734.8% | -11.5% | +44.4% | -5.3% | +216.7% |
| Free cash flow growth | -8.5% | -75.3% | +102.5% | — | -117.5% | +849.5% | +29.5% | -50.0% | -57.6% | +15.3% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000884269 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.